Improving Care Delivery for Cancer

DH
Overseen ByDavid Hui, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to enhance cancer care delivery by collecting patient feedback in oncology and supportive care clinics. Participants will complete a short questionnaire, have their clinic conversations recorded, and allow a review of their medical records. The goal is to help doctors better understand and improve the cancer care process. Those diagnosed with stage IV solid cancer in the last six months and receiving care at MD Anderson Cancer Center might be suitable candidates. As an unphased trial, this study offers a unique opportunity to directly influence and improve cancer care practices for future patients.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on collecting patient feedback rather than altering treatment plans.

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative ways to enhance cancer care delivery by integrating patient feedback and technology. Unlike traditional cancer treatments that focus solely on drugs and therapies, this approach emphasizes improving communication between patients and their healthcare teams through questionnaires and audio-recorded clinic conversations. By reviewing electronic health records, the trial aims to optimize how patient information is utilized, potentially leading to more personalized and efficient care. This method could reshape how treatment plans are developed and tailored, making the entire process more patient-centered and responsive to individual needs.

Who Is on the Research Team?

DH

David Hui

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

Within 6 months of diagnosis of metastatic (or stage IV) solid malignancies
Age 18 or greater
English speaking
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection

Participants complete questionnaires and undergo audio recording of clinic conversations

15-20 minutes per session

Follow-up

Participants' medical records are reviewed to assess supportive/palliative care delivery

through study completion, an average of 1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Discussion
  • Electronic Health Record Review
  • Questionnaire Administration
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Supportive Care (questionnaire, clinic conversation)Experimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security